Large gap with delayed quotes
|
Last quote
02/13/2026
-
17:32:14
|
Bid
02/13/2026 -
20:53:03
|
Bid Volume |
Ask
02/13/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
152.20
+1.70
(
+1.13% )
|
0.00
|
23 |
155.00
|
300 |
Analysis date: 13.02.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 16.12.2025.
Interest
Very weak
Very weak
One star since 20.01.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 19.12.2025 at a price of 162.80.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 20.01.2026.
4wk Rel Perf
-5.41%
-5.41%
The four-week dividend-adjusted underperformance versus STOXX600 is 5.41%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 07.03.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.10%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.65%.
Mkt Cap in $bn
45.96
45.96
With a market capitalization >$8bn, GALDERMA GROUP is considered a large-cap stock.
G/PE Ratio
1.13
1.13
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
32.09
32.09
The estimated PE is for the year 2027.
LT Growth
36.01%
36.01%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.34%
0.34%
The twelve month estimated dividend yield represents 10.80% of earnings forecasts.
Beta
166
166
For 1% of index variation, the stock varies on average by 1.66%.
Correlation
0.57
0.57
57.42% of stock movements are explained by index variations.
Value at Risk
36.53
36.53
The value at risk is estimated at CHF 36.53. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
23.08.2024
23.08.2024